Skip to main content
. 2005 Jun;43(6):2929–2931. doi: 10.1128/JCM.43.6.2929-2931.2005

TABLE 1.

Index of reactivity of heat-treated and not treated soluble antigens from suspensions of clinical and reference strains of Cryptococcus spp. in the Platelia Aspergillus assaya

Strain designation Site of isolation Identification Index of reactivity in expt:
1 (no heat treatment) 2 (no heat treatment) 3 (heat treatment)
44 CSF C. neoformans 4.8 >5 3.4
101 Blood culture C. neoformans 4.7 >5 3.1
294 Blood culture C. neoformans >5 >5 >5
545 CSF C. neoformans 3.8 >5 3.3
590 Urine C. neoformans serotype A >5 >5 >5
648 Blood culture C. neoformans serotype A 4.1 >5 >5
681 CSF C. neoformans serotype A 3.6 >5 >5
861 CSF C. neoformans 4.8 >5 3.4
1451 CSF Cryptococcus sp. 5 >5 3.4
1782 BAL C. neoformans serotype D >5 >5 >5
1829 Blood culture C. neoformans serotype A 3.5 >5 >5
2323 Toe nail C. laurentii >5 >5 >5
2500b Blood culture C. neoformans serotype A 4.9 >5 3.5
2501b Sputum C. neoformans serotype A 4 >5 >5
NIH 68 Reference strain C. neoformans serotype A ND 3.1 2.6
NIH 112B Reference strain C. neoformans serotype B ND >5 >5
NIH 52D Reference strain C. neoformans serotype D ND 2.8 2.2
CDC B.238 Reference strain C. neoformans serotype C ND >5 >5
Cap 67 Reference strain C. neoformans non typable ND >5 3.5
a

CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; ND, not done. Experiments 2 and 3 were performed on the same antigenic extracts.

b

Isolates 2500 and 2501 were obtained from the patient described in this paper.